Search clinical trials for: Intravenous Cerebrolysin

Total 6444 results

Kwong Wah Hospital

Completed

Randomized, Double-blind, Placebo-controlled Trial to Investigate Safety and Efficacy of Cerebrolysin™ in Patients With Aneurysmal Subarachnoid Hemorrhage (CESAR)

Subarachnoid Hemorrhage | Delayed Cerebral Ischemia | Intracranial Aneurysm | Delayed Ischemic Neurological Deficit

China
Ever Neuro Pharma GmbH
acromion GmbH

Completed

Comparative Study to Test Safety and Efficacy of Neurotrophic and Cholinergic Treatment of Alzheimer's Disease (Combi)

Alzheimer Disease

Spain
Mansoura University Children Hospital

Completed

the Effect of Cerebrolysin on Physical and Mental Functions of Down Syndrome

Down Syndrome

Egypt
Samsung Medical Center

Completed

Effects of Cerebrolysin on Motor Recovery in Patients With Subacute Stroke (E-COMPASS)

Cerebrolysin

Korea, Republic of
Sahar M.A. Hassanein, MD

Completed

Study of Cerebrolysin for Treatment of Infants With History of Neonatal Hypoxic Ischemic Encephalopathy (CerebroHIE)

Hypoxic-Ischemic Encephalopathy

Egypt
Clinical Institute of the Brain, Russia

Unknown

Comprehensive Reparative Therapy in Ischemic Stroke COMplex Repair in Ischemic Stroke-Arm

Ischemic Stroke

Russian Federation
Ain Shams University

Unknown

Cerebrolysin Neural Repair Therapy in Children With Traumatic Brain Injury and Cerebral Palsy

Mental Handicap | Cerebral Palsy Children | Children With Traumatic Brain Injury | Delayed Speech Development

Egypt
Clinical Institute of the Brain, Russia
Ever Neuro Pharma GmbH; Nycomed; Veropharm

Completed

Navigation Brain Stimulation for Evaluation of the Neuroprotective Drug Efficiency in Patients After Ischemic Stroke. (3C)

Stroke

Russian Federation
Mansoura University Children Hospital

Completed

Cerebrolysin and Neurodevelopment in Preterm Infants

Cerebral Palsy | Infant Development | Preterm Infant

Egypt
Hospital Universitario Dr. Jose E. Gonzalez
Ever Neuro Pharma GmbH

Recruiting

Effect of Cerebrolysin on the Blood Brain Barrier in Patients With Diabetes and Ischemic Stroke

Diabetes Mellitus, Type 2 | Ischemic Stroke, Acute | Blood Brain Barrier

Mexico
Chang Gung Memorial Hospital

Not yet recruiting

Exploring Cerebrolysin in Late Thrombectomy for Stroke: Blood-brain Barrier Biomarkers and Imaging Insights

Acute Ischemic Stroke
Pomeranian Medical University Szczecin

Recruiting

Early Administration of Cerebrolysin on the Outcome of Patients With Acute Stroke Undergoing EVT

Stroke, Acute, Ischemic

Poland
Assiut University

Completed

Cerebrolycin for Treatment of Covid-related Anosmia and Ageusia

Covid19 Related Anosmia and Aguesia

Egypt
Shaare Zedek Medical Center

Recruiting

A Prospective, Trial About Safety and Efficacy of Combined Treatment With Cerebrolysin in Acute Ischemic Hemispheric Stroke Patients Undergoing EndoVascular Treatment (EVT)

Acute Ischemic Stroke

Israel
Medical University of Lublin

Enrolling by invitation

Cerebrolysin in Prevention of Postoperative Delirium in Cardiac Surgery (Cereb-POD)

Neurocognitive Disorders | Critical Illness | Cardiac Disease | Brain Damage | Surgery-Complications

Poland
Pomeranian Medical University Szczecin

Completed

Evaluation of the Effect of Neuroprotective Drug on Treatment Result in Patients After Traumatic Brain Injury

TBI (Traumatic Brain Injury)

Poland
Ever Neuro Pharma GmbH
XClinical GmbH; idv Datenanalyse & Versuchsplanung

Recruiting

CERebrolysin In CADASIL (CERICA)

Cadasil

Czechia
Samsung Medical Center
Ever Neuro Pharma GmbH

Completed

Effects of Cerebrolysin Combined With Rehabilitation on Motor Recovery in Stroke

Stroke

Korea, Republic of
Military Institute of Medicine, Poland
Brainomix Limited

Recruiting

Efficacy of Cerebrolysin Treatment as an add-on Therapy to Mechanical Thrombectomy in Acute Ischemic Stroke.

Stroke, Ischemic | Stroke, Acute | Stroke Sequelae

Poland
Ever Neuro Pharma GmbH
SITS International

Terminated

Cerebrolysin REGistry Study in Stroke (CREGS-S)

Ischemic Stroke

Austria
Yonsei University

Recruiting

Effects of Cerebrolysin on Level of Consciousness and Brain Metabolism in Disorder of Consciousness After Stroke: Single Center Randomized Controlled Study

Stroke

Korea, Republic of
Konkuk University Medical Center
Ever Neuro Pharma GmbH

Not yet recruiting

Efficacy and Safety of Cerebrolysin on Prolonged Disorders of Consciousness

Disorder of Consciousness | Hemorrhagic Stroke

Korea, Republic of
Ever Neuro Pharma GmbH
IDV Data analysis and study planning Dr. Rahlfs

Recruiting

Cerebrolysin REGistry Study in Stroke - a High-quality Observational Study of Comparative Effectiveness (C-REGS2)

Acute Ischemic Stroke

Austria
Universidad Autonoma de Nuevo Leon
Hospital Universitario Dr. Jose E. Gonzalez

Completed

Hair Repigmentation During Cerebrolysin Therapy

Hair Problems

Mexico
Sherifa Ahmed Hamed

Completed

Clinical Characteristics and Treatment of Anosmia and Ageusia Due to SARS-CoV2 Variants

Post-covid-19 Persistent Smell and Taste Disorders

Egypt
Ever Neuro Pharma GmbH
VASCage GmbH

Terminated

IMPULSE - StIMulation of Brain Plasticity to Improve Upper Limb Recovery After StrokE (IMPULSE)

Chronic Stroke | Subacute Stroke

Austria
Ever Neuro Pharma GmbH
JSW-Research Forschungslabor GmbH, Parkring 12, 8074 Grambach

Completed

Combined Treatment With Alteplase (Rt-PA) and Cerebrolysin® in Acute Ischemic Hemispheric Stroke (CERE-LYSE-1)

Stroke

Austria, Croatia, Czech Republic, Slovakia, Slovenia
Ever Neuro Pharma GmbH
Excel PharmaStudies, Inc.; idv Datenanalyse und Versuchsplanung

Completed

The Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic Stroke (CASTA)

Ischemic Stroke

Korea, Republic of, China, Hong Kong
Ever Neuro Pharma GmbH

Terminated

The CAPTAIN Trial: Cerebrolysin Asian Pacific Trial in Acute Brain Injury and Neurorecovery (CAPTAIN)

Traumatic Brain Injury

Hong Kong
Ever Neuro Pharma GmbH
acromion GmbH; Geny Research Corp.

Completed

A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia (VascDem)

Vascular Dementia

Russian Federation
Poznan University of Medical Sciences

Recruiting

CERebrolysine Effect on Blood-brain Barrier in acUte Ischemic Stroke (CERBERUS)

Acute Ischemic Stroke

Poland
Yuzuncu Yıl University

Unknown

Powder Topical Rifampicin on Reducing Infections After Neural Tube Defect Surgery in Infants

Postoperative Infection Rates

Turkey
Royan Institute

Completed

Autologous Bone Marrow Derived Mesenchymal Stromal Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD)

Chronic Kidney Disease

Iran, Islamic Republic of
Mongi Slim Hospital

Completed

Prevention of Bleeding in Total Joint Replacement: Combined Route Administration of Tranexamic Acid

Arthroplasty, Replacement, Knee | Blood Transfusion | Arthroplasty, Replacement, Hip | Tranexamic Acid

Tunisia
University of Minnesota

Completed

Enhanced Nutrition for Preterm Infants

Preterm Birth

United States
Galapagos NV
MorphoSys AG

Completed

First in Human of Single and Multiple Doses of MOR106

Healthy | Dermatitis, Atopic

Belgium, Hungary, Moldova, Republic of, Romania
Baxalta now part of Shire

Completed

Study to Determine the Dose of Recombinant Human Hyaluronidase Needed to Infuse a Full Dose of IGIV Subcutaneously

Primary Immunodeficiency Diseases (PID)

United States
Astellas Pharma Europe B.V.

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP6294 Administered Intravenously or Subcutaneously in Healthy Young Male and Female Subjects

Healthy Subjects | Pharmacokinetics of ASP6294

United Kingdom
MicuRx
Worldwide Clinical Trials

Completed

Single Dose Escalation and Multiple Dose Escalation Trial of an Intravenous Formulation of MRX-4

Safety
Asklepion Pharmaceuticals, LLC

Completed

Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol

Atrial Septal Defect | Atrioventricular Septal Defect | Ventricular Septal Defect

United States
Eli Lilly and Company

Completed

A Study of LY3016859 in Healthy Volunteers

Healthy Volunteers

United Kingdom
Chaitanya Hospital, Pune

Unknown

Study Safety and Efficacy of BMMNC for the Patient With Duchenne Muscular Dystrophy (BMMNC)

Muscular Dystrophy | Duchenne Muscular Dystrophy

India
October 6 University

Recruiting

Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy

Bell Palsy

Egypt
GlaxoSmithKline

Completed

SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS

Lung Injury, Acute

United States
Andalusian Initiative for Advanced Therapies -...
Iniciativa Andaluza en Terapias Avanzadas

Completed

A Multicenter Phase I/II Clinical Trial to Evaluate Safety of Mesenchymal Stem Cell in Patients With Amyotrophic Sclerosis Lateral

Amyotrophic Lateral Sclerosis

Spain
UCB Celltech
Parexel

Completed

A First-In-Human Study With a Single Dose UCB7665 in Healthy Volunteers

Healthy

United Kingdom
Centre Hospitalier Departemental Vendee
Institut National de la Santé Et de la Recherche Médicale, France; Ministry... and other collaborators

Terminated

Impact of Early Enteral vs. Parenteral Nutrition on Preservation of Gut Mucosa Integrity in Patients Requiring Mechanical Ventilation and Catecholamine

Shock | Acute Respiratory Failure

France
Novartis Pharmaceuticals

Completed

MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS)

Pigmented Villonodular Synovitis | PVNS | Giant Cell Tumor of the Tendon Sheath | GCCTS | Tenosynovial Giant Cell Tumor Localized or Diffused Type | GCTS

United States, Switzerland
University of Foggia

Unknown

Evaluation of the Active Warming Effects on Maternal and Neonatal Outcome During Cesarean Delivery

Hypothermia; Anesthesia

Italy
Centre Hospitalier Departemental Vendee
Institut National de la Santé Et de la Recherche Médicale, France; Ministry... and other collaborators

Terminated

Impact of Early Enteral vs. Parenteral Nutrition on Risk of Gastric-Content Aspiration in Patients Requiring Mechanical Ventilation and Catecholamines

Shock | Acute Respiratory Failure

France

Search clinical trials for: Intravenous Cerebrolysin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations